EAP
Showing 1 - 25 of 333
Dravet Syndrome, Lennox Gastaut Syndrome, Developmental and Epileptic Encephalopathies Trial run by the Longboard
Available
- Dravet Syndrome
- +2 more
-
Bethesda, MarylandMid-Atlantic Epilepsy and Sleep Center
Nov 19, 2023
Acute Myeloid Leukemia, MDS Trial (Galinpepimut-S)
Available
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Galinpepimut-S
- (no location specified)
Oct 20, 2022
Multiple Myeloma Trial (Cilta-cel OOS Therapy)
Available
- Multiple Myeloma
- Cilta-cel OOS Therapy
- (no location specified)
Aug 15, 2022
Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)
Available
- Clear Cell Renal Cell Carcinoma
- 89Zr-DFO-girentuximab
-
Los Angeles, CaliforniaUCLA
Oct 12, 2023
Multiple Myeloma Trial (Nonconforming idecabtagene vicleucel)
Available
- Multiple Myeloma
- Nonconforming idecabtagene vicleucel
- (no location specified)
Feb 7, 2022
Glioblastoma Trial in Durham (PVSRIPO)
No longer available
- Glioblastoma
- PVSRIPO
-
Durham, North CarolinaDuke University Medical Center
Jun 23, 2022
Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)
Recruiting
- Hematological Malignancy
- Etoposide
- +2 more
-
Ningbo, Zhejiang, ChinaThe Affiliated People's Hospital of Ningbo University.
Aug 18, 2022
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematological Tumor
Approved for marketing
- Advanced Systemic Mastocytosis
- +3 more
- (no location specified)
Oct 5, 2021
Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)
Available
- Large B-cell Lymphoma
- +4 more
- Epcoritamab
- (no location specified)
Feb 16, 2023
Ebola Virus Disease Trial (REGN3470-3471-3479)
Available
- Ebola Virus Disease
- REGN3470-3471-3479
- (no location specified)
Apr 25, 2022
Post Traumatic Stress Disorder Trial in United States (Prolonged Exposure for Primary Care (PE-PC), EAP Treatment as Usual
Not yet recruiting
- Post Traumatic Stress Disorder
- Prolonged Exposure for Primary Care (PE-PC)
- EAP Treatment as Usual (TAU)
-
San Diego, California
- +6 more
Feb 20, 2023
Primary Generalized Tonic-Clonic or Partial Onset Seizures, Lennox Gastaut Syndrome Trial in Worldwide (Perampanel)
Available
- Primary Generalized Tonic-Clonic or Partial Onset Seizures
- Lennox Gastaut Syndrome
-
Brussels, Belgium
- +21 more
May 25, 2022
Self Efficacy Trial in Spain (Impact of a training program)
Completed
- Self Efficacy
- Impact of a training program
-
Arenys de Mar, Barcelona, Spain
- +9 more
Apr 26, 2021
Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber) Trial (GS010)
Available
- Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber)
- GS010
- (no location specified)
Aug 2, 2021
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) Trial (Remestemcel-L,
Available
- Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
- Remestemcel-L
- +2 more
- (no location specified)
Apr 12, 2022
COVID, SARSCoV2 Convalescent Plasma Trial in Orlando (SARSCoV2 Convalescent Plasma)
No longer available
- COVID
- SARSCoV2 Convalescent Plasma
- SARSCoV2 Convalescent Plasma
-
Orlando, FloridaAdventHealth Orlando
May 4, 2021
Lymphoma, Multiple Myeloma Trial in China (Etoposide, Cytarabine, PEG-rhG-CSF)
Recruiting
- Lymphoma
- Multiple Myeloma
- Etoposide
- +2 more
-
Hangzhou, Zhejiang, China
- +6 more
Sep 7, 2022
Relapsed or Refractory DLBCL (R/R DLBCL) Trial (Loncastuximab Tesirine)
No longer available
- Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
- Loncastuximab Tesirine
- (no location specified)
May 10, 2021